Steroid shown to reduce COVID-19 mortality approved for immediate NHS use

Findings from the ongoing RECOVERY trial show that treatment with low-dose dexamethasone reduces mortality in COVID-19 patients with severe respiratory complications.

by Lisa Lytle
Dexamethasone should now be considered part of standard care in COVID-19 patients requiring oxygen, including those on a ventilator. | GETTY IMAGES
Dexamethasone should now be considered part of standard care in COVID-19 patients requiring oxygen, including those on a ventilator. | GETTY IMAGES

Sign in to continue

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package